HOLX
Hologic Inc
NASDAQ: HOLX · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$76.01
+0.00% today
Updated 2026-04-07
Market cap
$16.97B
P/E ratio
31.54
P/S ratio
4.11x
EPS (TTM)
$2.41
Dividend yield
—
52W range
$52 – $76
Volume
5.0M
Hologic Inc (HOLX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
13.20%
Operating margin
23.00%
ROE
10.90%
ROA
7.43%
Debt/equity
0.48x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $462.68M | $27.42M | 41.83% | 10.88% | 5.93% |
| 2007 | $738.37M | $94.58M | 46.80% | 20.01% | 12.81% |
| 2008 | $1.67B | $-385.62M | 53.30% | -11.80% | -23.03% |
| 2009 | $1.64B | $-2.18B | 52.38% | -123.18% | -132.93% |
| 2010 | $1.68B | $-62.81M | 43.86% | 4.16% | -3.74% |
| 2011 | $1.79B | $157.15M | 51.59% | 20.93% | 8.78% |
| 2012 | $2.00B | $-73.63M | 49.66% | 5.68% | -3.68% |
| 2013 | $2.49B | $-1.17B | 46.60% | -36.36% | -47.06% |
| 2014 | $2.53B | $17.30M | 49.22% | 11.05% | 0.68% |
| 2015 | $2.71B | $131.60M | 52.96% | 16.82% | 4.87% |
| 2016 | $2.83B | $330.80M | 55.19% | 19.37% | 11.68% |
| 2017 | $3.06B | $755.50M | 52.99% | 44.80% | 24.70% |
| 2018 | $3.22B | $-111.30M | 52.73% | -7.39% | -3.46% |
| 2019 | $3.37B | $-40.20M | 38.85% | 3.99% | -1.19% |
| 2020 | $3.78B | $1.12B | 58.98% | 29.26% | 29.53% |
| 2021 | $5.63B | $1.87B | 67.39% | 44.04% | 33.23% |
| 2022 | $4.86B | $1.30B | 61.64% | 33.73% | 26.77% |
| 2023 | $4.03B | $456.00M | 51.40% | 16.58% | 11.31% |
| 2024 | $4.03B | $789.50M | 55.28% | 21.90% | 19.59% |
| 2025 | $4.10B | $565.70M | 61.00% | 17.42% | 13.80% |